--- schema_version: "secwatch.filing_event.v1" accession: "0001140361-24-007429" form_type: "8-K" ticker: "CI" cik: "0001739940" company_name: "Cigna Group" filed_at: "2024-02-13T23:59:59+00:00" generated_at: "2026-06-06T03:30:13.581620+00:00" event_type: "debt" sentiment: "neutral" materiality_score: 0.6 calibrated_materiality_score: 0.6 confidence: "high" source: SEC EDGAR --- # Cigna issues $4.5B in senior notes across four tranches to fund tender offers and refinancing ## Summary - Issued $1.0B 5.000% notes due 2029, $750M 5.125% notes due 2031, $1.25B 5.250% notes due 2034, $1.5B 5.600% notes due 2054. - Proceeds will fund tender offers for up to $2.25B of outstanding notes maturing 2024-2030. - Remaining proceeds to repay 0.613% Senior Notes due March 2024 and for general corporate purposes including share repurchases. ## SEC filing metadata - accession: 0001140361-24-007429 - form_type: 8-K - ticker: CI - cik: 0001739940 - company_name: Cigna Group - filed_at: 2024-02-13T23:59:59+00:00 - event_type: debt - sentiment: neutral - materiality_score: 0.6 - calibrated_materiality_score: 0.6 - confidence: high - sec_items: 1.01, 2.03, 7.01, 8.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/0001140361-24-007429-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/ny20020170x6_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001140361-24-007429 - JSON: https://secwatch.observer/filing/0001140361-24-007429.json - Plain text: https://secwatch.observer/filing/0001140361-24-007429.txt ## Key facts - Debt Financings Cigna Group incurred senior notes of $1.25 billion in aggregate principal amount of its 5.250% Senior Notes due 2034 with U.S. Bank Trust Company, National Association at 5.250% maturing due 2034. - Instrument: senior notes - Principal: $1.25 billion in aggregate principal amount of its 5.250% Senior Notes due 2034 - Counterparty: U.S. Bank Trust Company, National Association - Rate: 5.250% - Maturity: due 2034 - Event: incurrence source text: Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. evidence_url: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/0001140361-24-007429-index.htm - Debt Financings Cigna Group incurred senior notes of $1.5 billion in aggregate principal amount of its 5.600% Senior Notes due 2054 with U.S. Bank Trust Company, National Association at 5.600% maturing due 2054. - Instrument: senior notes - Principal: $1.5 billion in aggregate principal amount of its 5.600% Senior Notes due 2054 - Counterparty: U.S. Bank Trust Company, National Association - Rate: 5.600% - Maturity: due 2054 - Event: incurrence source text: Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. evidence_url: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/0001140361-24-007429-index.htm - Debt Financings Cigna Group incurred senior notes of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029 with U.S. Bank Trust Company, National Association at 5.000% maturing due 2029. - Instrument: senior notes - Principal: $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029 - Counterparty: U.S. Bank Trust Company, National Association - Rate: 5.000% - Maturity: due 2029 - Event: incurrence source text: On February 13, 2024, The Cigna Group (the “Company” or “our”) completed its previously announced offering of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029 evidence_url: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/0001140361-24-007429-index.htm - Debt Financings Cigna Group incurred senior notes of $750 million in aggregate principal amount of its 5.125% Senior Notes due 2031 with U.S. Bank Trust Company, National Association at 5.125% maturing due 2031. - Instrument: senior notes - Principal: $750 million in aggregate principal amount of its 5.125% Senior Notes due 2031 - Counterparty: U.S. Bank Trust Company, National Association - Rate: 5.125% - Maturity: due 2031 - Event: incurrence source text: Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. evidence_url: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/0001140361-24-007429-index.htm - Material Agreements Cigna Group entered into Supplemental Indenture No. 7 with U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (effective 2024-02-13). - Action: entry - Agreement: notes offering - Counterparty: U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee - Effective: 2024-02-13 source text: The terms of the Notes are governed by an Indenture, dated as of September 17, 2018 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. 7 to the Base Indenture, dated as of February 13, 2024 (“Supplemental Indenture No. 7”), between the Company and the Trustee. evidence_url: https://www.sec.gov/Archives/edgar/data/1739940/000114036124007429/0001140361-24-007429-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.